Artículos de revistas sobre el tema "IGF Type 2"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "IGF Type 2".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Hansenne, Isabelle Sylvie, Chantal Renard y Vincent Geenen. "Igf2 expression is required for complete tolerance to insulin (128.19)". Journal of Immunology 178, n.º 1_Supplement (1 de abril de 2007): S213—S214. http://dx.doi.org/10.4049/jimmunol.178.supp.128.19.
Texto completoBallard, F. J., M. Ross, F. M. Upton y G. L. Francis. "Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively". Biochemical Journal 249, n.º 3 (1 de febrero de 1988): 721–26. http://dx.doi.org/10.1042/bj2490721.
Texto completoLouis, Céline, Chantal Renard, Alain Bosseloir, Ilse Weets, Frans Gorus y Vincent Geenen. "Humoral and cellular immune responses to IGF-2 in type 1 diabetes (128.21)". Journal of Immunology 178, n.º 1_Supplement (1 de abril de 2007): S214. http://dx.doi.org/10.4049/jimmunol.178.supp.128.21.
Texto completoRosenzweig, Steven A. "The Continuing Evolution of Insulin-like Growth Factor Signaling". F1000Research 9 (23 de marzo de 2020): 205. http://dx.doi.org/10.12688/f1000research.22198.1.
Texto completoAl-janaby, Mohammed Salih, Mohammed Qais Al-ani y Marrib N. Rasheed. "RELATIONSHIP BETWEEN SOME IMMUNOLOGICAL FACTORS AND TYPE 2 DIABETES MELLITUS IN IRAQI PATIENTS". Asian Journal of Pharmaceutical and Clinical Research 11, n.º 6 (7 de junio de 2018): 489. http://dx.doi.org/10.22159/ajpcr.2018.v11i6.25881.
Texto completoBallard, F. J., L. C. Read, G. L. Francis, C. J. Bagley y J. C. Wallace. "Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts". Biochemical Journal 233, n.º 1 (1 de enero de 1986): 223–30. http://dx.doi.org/10.1042/bj2330223.
Texto completoSchuller, A. G. P., J. W. van Neck, R. W. Beukenholdt, E. C. Zwarthoff y S. L. S. Drop. "IGF, type I IGF receptor and IGF-binding protein mRNA expression in the developing mouse lung". Journal of Molecular Endocrinology 14, n.º 3 (junio de 1995): 349–55. http://dx.doi.org/10.1677/jme.0.0140349.
Texto completoWasim, H., M. Abdelmonem, S. Samir y A. Salah. "Monitoring Of IGF-1 Levels In Type 2 Diabetic Patients With Macro And Microvascular Complications". American Journal of Clinical Pathology 154, Supplement_1 (octubre de 2020): S127—S128. http://dx.doi.org/10.1093/ajcp/aqaa161.279.
Texto completoNarayanan, Ram P., Matthew Gittins, Kirk W. Siddals, Robert L. Oliver, Julie E. Hudson, Anne White, Paul Durrington, Robert R. Davies, Martin K. Rutter y J. Martin Gibson. "Atorvastatin administration is associated with dose-related changes in IGF bioavailability". European Journal of Endocrinology 168, n.º 4 (abril de 2013): 543–48. http://dx.doi.org/10.1530/eje-12-0844.
Texto completoKirk, S. P., M. A. Whittle, J. M. Oldham, P. M. Dobbie y J. J. Bass. "GH regulation of the Type 2 IGF receptor in regenerating skeletal muscle of rats". Journal of Endocrinology 149, n.º 1 (abril de 1996): 81–91. http://dx.doi.org/10.1677/joe.0.1490081.
Texto completoNarayanan, Ram P., Bo Fu, Adrian H. Heald, Kirk W. Siddals, Robert L. Oliver, Julie E. Hudson, Antony Payton et al. "IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes". Endocrine Connections 1, n.º 2 (noviembre de 2012): 95–102. http://dx.doi.org/10.1530/ec-12-0053.
Texto completoCohen, Dara Hope y Derek LeRoith. "Obesity, type 2 diabetes, and cancer: the insulin and IGF connection". Endocrine-Related Cancer 19, n.º 5 (octubre de 2012): F27—F45. http://dx.doi.org/10.1530/erc-11-0374.
Texto completoMcCusker, RH y J. Novakofski. "Zinc partitions IGFs from soluble IGF binding proteins (IGFBP)-5, but not soluble IGFBP-4, to myoblast IGF type 1 receptors". Journal of Endocrinology 180, n.º 2 (1 de febrero de 2004): 227–46. http://dx.doi.org/10.1677/joe.0.1800227.
Texto completoHøjlund, Kurt, Henning Beck-Nielsen, Allan Flyvbjerg y Jan Frystyk. "Characterisation of adiponectin multimers and the IGF axis in humans with a heterozygote mutation in the tyrosine kinase domain of the insulin receptor gene". European Journal of Endocrinology 166, n.º 3 (marzo de 2012): 511–19. http://dx.doi.org/10.1530/eje-11-0790.
Texto completoRoss, M., G. L. Francis, L. Szabo, J. C. Wallace y F. J. Ballard. "Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-1". Biochemical Journal 258, n.º 1 (15 de febrero de 1989): 267–72. http://dx.doi.org/10.1042/bj2580267.
Texto completoPratipanawatr, Thongchai, Wilailak Pratipanawatr, Clifford Rosen, Rachele Berria, Mandeep Bajaj, Kenneth Cusi, Lawrence Mandarino, Sangeta Kashyap, Renata Belfort y Ralph A. DeFronzo. "Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects". American Journal of Physiology-Endocrinology and Metabolism 282, n.º 6 (1 de junio de 2002): E1360—E1368. http://dx.doi.org/10.1152/ajpendo.00335.2001.
Texto completoFournier, Mario y Michael I. Lewis. "Influences of IGF-I gene disruption on the cellular profile of the diaphragm". American Journal of Physiology-Endocrinology and Metabolism 278, n.º 4 (1 de abril de 2000): E707—E715. http://dx.doi.org/10.1152/ajpendo.2000.278.4.e707.
Texto completoMannucci, Edoardo. "Insulin Therapy and Cancer in Type 2 Diabetes". ISRN Endocrinology 2012 (14 de noviembre de 2012): 1–12. http://dx.doi.org/10.5402/2012/240634.
Texto completoHaeri, Nami Safai, Hussain Mahmud y Mary T. Korytkowski. "Paraneoplastic Hypoglycemia Leading to Insulin Independence in a Patient With Type 1 Diabetes". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A1003—A1004. http://dx.doi.org/10.1210/jendso/bvab048.2053.
Texto completoNoveral, J. P., A. Bhala, R. L. Hintz, M. M. Grunstein y P. Cohen. "Insulin-like growth factor axis in airway smooth muscle cells". American Journal of Physiology-Lung Cellular and Molecular Physiology 267, n.º 6 (1 de diciembre de 1994): L761—L765. http://dx.doi.org/10.1152/ajplung.1994.267.6.l761.
Texto completoOldham, J. M., A. K. Hodges, P. N. Schaare, P. C. Molan y J. J. Bass. "Nutritional dependence of insulin-like growth factor (IGF) receptors in skeletal muscle: measurement by light microscopic autoradiography." Journal of Histochemistry & Cytochemistry 41, n.º 3 (marzo de 1993): 415–21. http://dx.doi.org/10.1177/41.3.8429204.
Texto completoRead, L. C., F. J. Ballard, G. L. Francis, R. C. Baxter, C. J. Bagley y J. C. Wallace. "Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1". Biochemical Journal 233, n.º 1 (1 de enero de 1986): 215–21. http://dx.doi.org/10.1042/bj2330215.
Texto completoRasmussen, Søren K., Corinne Lautier, Lars Hansen, Søren M. Echwald, Torben Hansen, Claus T. Ekstrøm, Søren A. Urhammer et al. "Studies of the Variability of the Genes Encoding the Insulin-Like Growth Factor I Receptor and Its Ligand in Relation to Type 2 Diabetes Mellitus1". Journal of Clinical Endocrinology & Metabolism 85, n.º 4 (1 de abril de 2000): 1606–10. http://dx.doi.org/10.1210/jcem.85.4.6494.
Texto completoWathes, D. Claire, Zhangrui Cheng, Mark A. Fenwick, Richard Fitzpatrick y Joe Patton. "Influence of energy balance on the somatotrophic axis and matrix metalloproteinase expression in the endometrium of the postpartum dairy cow". REPRODUCTION 141, n.º 2 (febrero de 2011): 269–81. http://dx.doi.org/10.1530/rep-10-0177.
Texto completoLarina, V. N. y V. I. Lunev. "The prognostic role of the index of global left ventricular function and its companion in patients with chronic heart failure and diabetes mellitus". FOCUS. Endocrinology 5, n.º 2 (13 de mayo de 2024): 6–11. http://dx.doi.org/10.62751/2713-0177-2024-5-2-11.
Texto completoJiang, Sheng y Jing Yang. "Association of insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 with estimated glomerular filtration rate in patients with type 2 diabetes mellitus". Global Translational Medicine 1, n.º 2 (21 de septiembre de 2022): 62. http://dx.doi.org/10.36922/gtm.v1i2.62.
Texto completoTally, Michael, Choh Hao Li y Kerstin Hall. "IGF-2 stimulated growth mediated by the somatomedin type 2 receptor". Biochemical and Biophysical Research Communications 148, n.º 2 (octubre de 1987): 811–16. http://dx.doi.org/10.1016/0006-291x(87)90948-x.
Texto completoWestwood, M. "THE IGF AXIS AT THE FETO-MATERNAL INTERFACE". Reproductive Medicine Review 9, n.º 3 (octubre de 2001): 173–96. http://dx.doi.org/10.1017/s096227990100031x.
Texto completoMunoz, A., P. Trigo, C. Riber, V. Malonda y F. Castejon. "A study of serum insulin-like growth factor type 1 (IGF-1) concentrations in resting untrained Andalusian horses: influence of age and gender". Veterinární Medicína 56, No. 5 (10 de junio de 2011): 231–42. http://dx.doi.org/10.17221/1562-vetmed.
Texto completoBraulke, T. "Type-2 IGF Receptor: A Multi-Ligand Binding Protein". Hormone and Metabolic Research 31, n.º 02/03 (enero de 1999): 242–46. http://dx.doi.org/10.1055/s-2007-978725.
Texto completoSimpson, Aaron D., Ying Wei Jenetta Soo, Guillaume Rieunier, Tamara Aleksic, Olaf Ansorge, Chris Jones y Valentine M. Macaulay. "Type 1 IGF receptor associates with adverse outcome and cellular radioresistance in paediatric high-grade glioma". British Journal of Cancer 122, n.º 5 (20 de diciembre de 2019): 624–29. http://dx.doi.org/10.1038/s41416-019-0677-1.
Texto completoOguchi, S., W. A. Walker y I. R. Sanderson. "Differentiation and Polarity Alter the Binding of IGF‐I to Human Intestinal Epithelial (Caco‐2) Cells". Journal of Pediatric Gastroenterology and Nutrition 20, n.º 2 (febrero de 1995): 148–55. http://dx.doi.org/10.1002/j.1536-4801.1995.tb11527.x.
Texto completoSolarek, W., A. M. Czarnecka, B. Escudier, Z. F. Bielecka, F. Lian y C. Szczylik. "Insulin and IGFs in renal cancer risk and progression". Endocrine-Related Cancer 22, n.º 5 (octubre de 2015): R253—R264. http://dx.doi.org/10.1530/erc-15-0135.
Texto completoHuynh, HoangDinh, Junke Zheng y Chengcheng Zhang. "IGF Binding Protein 2 Supports the Cycling of Hematopoietic Stem Cells." Blood 116, n.º 21 (19 de noviembre de 2010): 1604. http://dx.doi.org/10.1182/blood.v116.21.1604.1604.
Texto completoGeenen, Vincent y Olivier Dardenne. "Thymus Dysfunction in the Development of Type 1 Diabetes and Endocrine Autoimmune Diseases". European Endocrinology 05 (2009): 24. http://dx.doi.org/10.17925/ee.2009.05.00.24.
Texto completoZhang, Donglei, Menashe Bar-Eli, Sylvain Meloche y Pnina Brodt. "Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor". Journal of Biological Chemistry 279, n.º 19 (1 de marzo de 2004): 19683–90. http://dx.doi.org/10.1074/jbc.m313145200.
Texto completovan Neck, J. W., A. Flyvbjerg, A. G. P. Schuller, R. R. Rosato, C. Groffen, M. van Kleffens, D. Lindenbergh-Kortleve, I. Dørup y S. L. S. Drop. "IGF, type I IGF receptor and IGF-binding protein mRNA expression in kidney and liver of potassium-depleted and normal rats infused with IGF-I". Journal of Molecular Endocrinology 19, n.º 1 (agosto de 1997): 59–66. http://dx.doi.org/10.1677/jme.0.0190059.
Texto completoParker, E. A., A. Hegde, M. Buckley, K. M. Barnes, J. Baron y O. Nilsson. "Spatial and temporal regulation of GH–IGF-related gene expression in growth plate cartilage". Journal of Endocrinology 194, n.º 1 (julio de 2007): 31–40. http://dx.doi.org/10.1677/joe-07-0012.
Texto completoReynaud, Karine, Sylvie Chastant-Maillard, Séverine Batard, Sandra Thoumire y Philippe Monget. "IGF system and ovarian folliculogenesis in dog breeds of various sizes: is there a link?" Journal of Endocrinology 206, n.º 1 (20 de abril de 2010): 85–92. http://dx.doi.org/10.1677/joe-09-0450.
Texto completoChahar, Deeksha, Gyanendra Kumar Sonkar, Sangeeta Singh, Satyendra Kumar Sonkar y Mohammad Kaleem Ahmad. "Unraveling Epigenetic Signatures for Early Detection of Diabetes Nephropathy in Type 2 Diabetes: A Case–Control Investigation". Biomedical and Biotechnology Research Journal 8, n.º 1 (2024): 108–16. http://dx.doi.org/10.4103/bbrj.bbrj_289_23.
Texto completoShooter, G. K., B. Magee, M. A. Soos, G. L. Francis, K. Siddle y J. C. Wallace. "Insulin-like growth factor (IGF)-I A- and B-domain analogues with altered type 1 IGF and insulin receptor binding specificities". Journal of Molecular Endocrinology 17, n.º 3 (diciembre de 1996): 237–46. http://dx.doi.org/10.1677/jme.0.0170237.
Texto completoYazdanpanah, Mojgan, Fakhredin A. Sayed-Tabatabaei, Joop A. M. J. L. Janssen, Ingrid Rietveld, Albert Hofman, Theo Stijnen, Huibert A. P. Pols, Steven W. J. Lamberts, Jacqueline C. M. Witteman y Cornelia M. van Duijn. "IGF-I gene promoter polymorphism is a predictor of survival after myocardial infarction in patients with type 2 diabetes". European Journal of Endocrinology 155, n.º 5 (noviembre de 2006): 751–56. http://dx.doi.org/10.1530/eje.1.02276.
Texto completoBatchelor, D. C., A.-M. Hutchins, M. Klempt y S. J. M. Skinner. "Developmental changes in the expression patterns of IGFs, type 1 IGF receptor and IGF-binding proteins-2 and -4 in perinatal rat lung". Journal of Molecular Endocrinology 15, n.º 2 (octubre de 1995): 105–15. http://dx.doi.org/10.1677/jme.0.0150105.
Texto completoLogie, A., N. Boulle, V. Gaston, L. Perin, P. Boudou, Y. Le Bouc y C. Gicquel. "Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line". Journal of Molecular Endocrinology 23, n.º 1 (1 de agosto de 1999): 23–32. http://dx.doi.org/10.1677/jme.0.0230023.
Texto completoSmink, JJ, JA Koedam, JG Koster y SC van Buul-Offers. "Dexamethasone-induced growth inhibition of porcine growth plate chondrocytes is accompanied by changes in levels of IGF axis components". Journal of Endocrinology 174, n.º 2 (1 de agosto de 2002): 343–52. http://dx.doi.org/10.1677/joe.0.1740343.
Texto completoBiddle, C., C. H. Li, P. N. Schofield, V. E. Tate, B. Hopkins, W. Engstrom, N. S. Huskisson y C. F. Graham. "Insulin-like growth factors and the multiplication of Tera-2, a human teratoma-derived cell line". Journal of Cell Science 90, n.º 3 (1 de julio de 1988): 475–84. http://dx.doi.org/10.1242/jcs.90.3.475.
Texto completoLee, C. Y., F. W. Bazer y F. A. Simmen. "Expression of components of the insulin-like growth factor system in pig mammary glands and serum during pregnancy and pseudopregnancy: effects of oestrogen". Journal of Endocrinology 137, n.º 3 (junio de 1993): 473–83. http://dx.doi.org/10.1677/joe.0.1370473.
Texto completoValverde, Angela M., Cecilia Mur, Michael Brownlee y Manuel Benito. "Susceptibility to Apoptosis in Insulin-like Growth Factor-I Receptor-deficient Brown Adipocytes". Molecular Biology of the Cell 15, n.º 11 (noviembre de 2004): 5101–17. http://dx.doi.org/10.1091/mbc.e03-11-0853.
Texto completoViswambharan, Hema, Nadira Y. Yuldasheva, Helen Imrie, Katherine Bridge, Natalie J. Haywood, Anna Skromna, Karen E. Hemmings et al. "Novel Paracrine Action of Endothelium Enhances Glucose Uptake in Muscle and Fat". Circulation Research 129, n.º 7 (17 de septiembre de 2021): 720–34. http://dx.doi.org/10.1161/circresaha.121.319517.
Texto completoSoos, M. A., C. E. Field y K. Siddle. "Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity". Biochemical Journal 290, n.º 2 (1 de marzo de 1993): 419–26. http://dx.doi.org/10.1042/bj2900419.
Texto completo